<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-07-25" modified="2020-08-12" version="159">
<accession>Q15464</accession>
<accession>B9EGM0</accession>
<accession>D3DRQ5</accession>
<accession>Q504U5</accession>
<accession>Q5VUM8</accession>
<name>SHB_HUMAN</name>
<protein>
<recommendedName>
<fullName>SH2 domain-containing adapter protein B</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">SHB</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="19" last="27">
<title>Shb is a ubiquitously expressed Src homology 2 protein.</title>
<authorList>
<person name="Welsh M."/>
<person name="Mares J."/>
<person name="Karlsson T."/>
<person name="Lavergne C."/>
<person name="Breant B."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8302579"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PDGFRB</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="1475" last="1483">
<title>Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.</title>
<authorList>
<person name="Karlsson T."/>
<person name="Songyang Z."/>
<person name="Landgren E."/>
<person name="Lavergne C."/>
<person name="Di Fiore P.P."/>
<person name="Anafi M."/>
<person name="Pawson T."/>
<person name="Cantley L.C."/>
<person name="Claesson-Welsh L."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="7537362"/>
</citation>
<scope>INTERACTION WITH PDGFRB; FGFR1; EPS8 AND V-SRC</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="Oncogene" volume="13" first="955" last="961">
<title>Apoptosis of NIH3T3 cells overexpressing the Src homology 2 domain protein Shb.</title>
<authorList>
<person name="Karlsson T."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="8806685"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Cell Growth Differ." volume="9" first="757" last="766">
<title>The Src homology 2 domain protein Shb transmits basic fibroblast growth factor- and nerve growth factor-dependent differentiation signals in PC12 cells.</title>
<authorList>
<person name="Karlsson T."/>
<person name="Kullander K."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="9751119"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="891" last="901">
<title>Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins.</title>
<authorList>
<person name="Welsh M."/>
<person name="Songyang Z."/>
<person name="Frantz J.D."/>
<person name="Trueb T."/>
<person name="Reedquist K.A."/>
<person name="Karlsson T."/>
<person name="Miyazaki M."/>
<person name="Cantley L.C."/>
<person name="Band H."/>
<person name="Shoelson S.E."/>
</authorList>
<dbReference type="PubMed" id="9484780"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201607"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH GRB2; GRAP AND CD3Z</scope>
<scope>MUTAGENESIS OF ARG-435</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="28050" last="28057">
<title>Requirement of the Src homology 2 domain protein Shb for T cell receptor-dependent activation of the interleukin-2 gene nuclear factor for activation of T cells element in Jurkat T cells.</title>
<authorList>
<person name="Lindholm C.K."/>
<person name="Gylfe E."/>
<person name="Zhang W."/>
<person name="Samelson L.E."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="10488157"/>
<dbReference type="DOI" id="10.1074/jbc.274.39.28050"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH LAT AND PLCG1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Blood" volume="95" first="3403" last="3411">
<title>Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.</title>
<authorList>
<person name="Dixelius J."/>
<person name="Larsson H."/>
<person name="Sasaki T."/>
<person name="Holmqvist K."/>
<person name="Lu L."/>
<person name="Engstroem A."/>
<person name="Timpl R."/>
<person name="Welsh M."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="10828022"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Exp. Cell Res." volume="257" first="245" last="254">
<title>Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization.</title>
<authorList>
<person name="Hooshmand-Rad R."/>
<person name="Lu L."/>
<person name="Heldin C.-H."/>
<person name="Claesson-Welsh L."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="10837138"/>
<dbReference type="DOI" id="10.1006/excr.2000.4896"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PDGFRA</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Exp. Cell Res." volume="259" first="370" last="377">
<title>NGF-dependent neurite outgrowth in PC12 cells overexpressing the Src homology 2-domain protein shb requires activation of the Rap1 pathway.</title>
<authorList>
<person name="Lu L."/>
<person name="Anneren C."/>
<person name="Reedquist K.A."/>
<person name="Bos J.L."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="10964504"/>
<dbReference type="DOI" id="10.1006/excr.2000.4984"/>
</citation>
<scope>INTERACTION WITH CRK</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="296" first="929" last="936">
<title>IL-2 receptor signaling through the Shb adapter protein in T and NK cells.</title>
<authorList>
<person name="Lindholm C.K."/>
</authorList>
<dbReference type="PubMed" id="12200137"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02016-8"/>
</citation>
<scope>INTERACTION WITH IL2RB; IL2RG; JAK1 AND JAK3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Eur. J. Biochem." volume="269" first="3279" last="3288">
<title>Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.</title>
<authorList>
<person name="Lindholm C.K."/>
<person name="Henriksson M.L."/>
<person name="Hallberg B."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="12084069"/>
<dbReference type="DOI" id="10.1046/j.1432-1033.2002.03008.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZAP70; LCP2; VAV1 AND GRAP2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="2881" last="2893">
<title>The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.</title>
<authorList>
<person name="Cross M.J."/>
<person name="Lu L."/>
<person name="Magnusson P."/>
<person name="Nyqvist D."/>
<person name="Holmqvist K."/>
<person name="Welsh M."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="12181353"/>
<dbReference type="DOI" id="10.1091/mbc.e02-02-0103"/>
</citation>
<scope>INTERACTION WITH FGFR1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Mol. Med." volume="8" first="695" last="704">
<title>Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.</title>
<authorList>
<person name="Welsh N."/>
<person name="Makeeva N."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="12520086"/>
<dbReference type="DOI" id="10.1007/bf03402033"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IRS2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Cell. Signal." volume="15" first="171" last="179">
<title>The Shb adaptor protein causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial cells.</title>
<authorList>
<person name="Holmqvist K."/>
<person name="Cross M.J."/>
<person name="Riley D."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="12464388"/>
<dbReference type="DOI" id="10.1016/s0898-6568(02)00076-1"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PTK2/FAK1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="22267" last="22275">
<title>The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.</title>
<authorList>
<person name="Holmqvist K."/>
<person name="Cross M.J."/>
<person name="Rolny C."/>
<person name="Haegerkvist R."/>
<person name="Rahimi N."/>
<person name="Matsumoto T."/>
<person name="Claesson-Welsh L."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="15026417"/>
<dbReference type="DOI" id="10.1074/jbc.m312729200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KDR</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Exp. Cell Res." volume="308" first="381" last="393">
<title>Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.</title>
<authorList>
<person name="Rolny C."/>
<person name="Lu L."/>
<person name="Aagren N."/>
<person name="Nilsson I."/>
<person name="Roe C."/>
<person name="Webb G.C."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="15919073"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2005.04.020"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-388</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-307 AND SER-388</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-187</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="8 9 11 14 15 16 17 20 21 22">Adapter protein which regulates several signal transduction cascades by linking activated receptors to downstream signaling components. May play a role in angiogenesis by regulating FGFR1, VEGFR2 and PDGFR signaling. May also play a role in T-cell antigen receptor/TCR signaling, interleukin-2 signaling, apoptosis and neuronal cells differentiation by mediating basic-FGF and NGF-induced signaling cascades. May also regulate IRS1 and IRS2 signaling in insulin-producing cells.</text>
</comment>
<comment type="subunit">
<text evidence="5 7 9 10 11 12 13 14 15 16 18 19 21">Interacts with PTPN11 (By similarity). Interacts with phosphorylated 'Tyr-720' of the ligand-activated receptor PDGFRA via its SH2 domain. Interacts with the ligand-activated receptors PDGFRB, FGFR1, KDR/VEGFR2, IL2RB and IL2RG. Interacts with EPS8 and V-SRC. Interacts with GRB2 and GRAP. Interacts with CD3Z. Interacts with tyrosine-phosphorylated LAT upon T-cell antigen receptor activation. Interacts with PLCG1. Interacts with ZAP70, LCP2/SLP-76, VAV1 and GRAP2. Interacts with JAK1 and JAK3. Interacts with PTK2/FAK1. Interacts with CRK/CrKII. Interacts with IRS2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4402156">
<id>Q15464</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4402156">
<id>Q15464</id>
</interactant>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4402156">
<id>Q15464</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Cytoplasmic side</orientation>
</subcellularLocation>
<text>Associates with membrane lipid rafts upon TCR stimulation.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q15464-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q15464-2</id>
<name>2</name>
<sequence type="described" ref="VSP_019846 VSP_019847"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="21">Widely expressed.</text>
</comment>
<comment type="domain">
<text>The SH2 domain preferentially binds phosphopeptides with the consensus sequence Y-[TVI]-X-L and mediates interaction with PDGFRA, PDGFRB, FGRFR1, IL2RB, IL2RG, CD3Z and CRK/CrKII.</text>
</comment>
<comment type="PTM">
<text evidence="7">Phosphorylated upon PDGFRA, PDGFRB, TCR, IL2 receptor, FGFR1 or VEGFR2 activation.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH94765" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA53091" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="X75342">
<property type="protein sequence ID" value="CAA53091.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138752">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161448">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL583849">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58254.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58255.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC094765">
<property type="protein sequence ID" value="AAH94765.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136581">
<property type="protein sequence ID" value="AAI36582.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136582">
<property type="protein sequence ID" value="AAI36583.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43806.1">
<molecule id="Q15464-1"/>
</dbReference>
<dbReference type="PIR" id="I38228">
<property type="entry name" value="I38228"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003019.2">
<molecule id="Q15464-1"/>
<property type="nucleotide sequence ID" value="NM_003028.2"/>
</dbReference>
<dbReference type="SMR" id="Q15464"/>
<dbReference type="BioGRID" id="112358">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="IntAct" id="Q15464">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="Q15464"/>
<dbReference type="STRING" id="9606.ENSP00000366936"/>
<dbReference type="BindingDB" id="Q15464"/>
<dbReference type="iPTMnet" id="Q15464"/>
<dbReference type="PhosphoSitePlus" id="Q15464"/>
<dbReference type="BioMuta" id="SHB"/>
<dbReference type="DMDM" id="110816415"/>
<dbReference type="EPD" id="Q15464"/>
<dbReference type="jPOST" id="Q15464"/>
<dbReference type="MassIVE" id="Q15464"/>
<dbReference type="MaxQB" id="Q15464"/>
<dbReference type="PaxDb" id="Q15464"/>
<dbReference type="PeptideAtlas" id="Q15464"/>
<dbReference type="PRIDE" id="Q15464"/>
<dbReference type="ProteomicsDB" id="60600">
<molecule id="Q15464-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60601">
<molecule id="Q15464-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="4119">
<property type="antibodies" value="274 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000377707">
<molecule id="Q15464-1"/>
<property type="protein sequence ID" value="ENSP00000366936"/>
<property type="gene ID" value="ENSG00000107338"/>
</dbReference>
<dbReference type="GeneID" id="6461"/>
<dbReference type="KEGG" id="hsa:6461"/>
<dbReference type="UCSC" id="uc004aax.4">
<molecule id="Q15464-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6461"/>
<dbReference type="DisGeNET" id="6461"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000107338.9"/>
<dbReference type="GeneCards" id="SHB"/>
<dbReference type="HGNC" id="HGNC:10838">
<property type="gene designation" value="SHB"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000107338">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="600314">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15464"/>
<dbReference type="OpenTargets" id="ENSG00000107338"/>
<dbReference type="PharmGKB" id="PA35744"/>
<dbReference type="eggNOG" id="ENOG502RT81">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161591"/>
<dbReference type="HOGENOM" id="CLU_029444_0_0_1"/>
<dbReference type="InParanoid" id="Q15464"/>
<dbReference type="KO" id="K23697"/>
<dbReference type="OMA" id="PAAASCF"/>
<dbReference type="OrthoDB" id="1120795at2759"/>
<dbReference type="PhylomeDB" id="Q15464"/>
<dbReference type="TreeFam" id="TF325799"/>
<dbReference type="PathwayCommons" id="Q15464"/>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="SignaLink" id="Q15464"/>
<dbReference type="BioGRID-ORCS" id="6461">
<property type="hits" value="13 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SHB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SHB_(gene)"/>
<dbReference type="GenomeRNAi" id="6461"/>
<dbReference type="Pharos" id="Q15464">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q15464"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="Q15464">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000107338">
<property type="expression patterns" value="Expressed in amniotic fluid and 218 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q15464">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd10389">
<property type="entry name" value="SH2_SHB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035040">
<property type="entry name" value="SHB"/>
</dbReference>
<dbReference type="InterPro" id="IPR035045">
<property type="entry name" value="SHB_SH2"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15127:SF31">
<property type="entry name" value="PTHR15127:SF31"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="SH2 domain-containing adapter protein B" id="PRO_0000246324">
<location>
<begin position="1"/>
<end position="509"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="6">
<location>
<begin position="410"/>
<end position="504"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with LAT, PTK2/FAK1, JAK1 and JAK3" evidence="7 13">
<location>
<begin position="1"/>
<end position="410"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 3">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="187"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_019846" evidence="23">
<original>EFQRQESVRSQHKGIQLY</original>
<variation>GLQEAWRHSPSGCFPVGP</variation>
<location>
<begin position="280"/>
<end position="297"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_019847" evidence="23">
<location>
<begin position="298"/>
<end position="509"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with CD3Z. Alters LAT, PLCG1, VAV1 and LCP2 phosphorylation, MAP kinase signaling, Rac1 and JNK activation, intracellular calcium increase, activation of the nuclear factor for activation of T-cells and subsequent interleukin-2 expression which normally occur upon T-cells stimulation." evidence="21">
<original>R</original>
<variation>K</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA53091." ref="1" evidence="24">
<original>DFE</original>
<variation>HFQ</variation>
<location>
<begin position="91"/>
<end position="93"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA53091." ref="1" evidence="24">
<original>I</original>
<variation>S</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA53091." ref="1" evidence="24">
<original>S</original>
<variation>P</variation>
<location>
<position position="445"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10488157"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10828022"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10837138"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10964504"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12084069"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12181353"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12200137"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12464388"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12520086"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15026417"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15919073"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537362"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8302579"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8806685"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9484780"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751119"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="509" mass="55042" checksum="15C392A6EEB761D6" modified="2006-07-25" version="2">MAKWLNKYFSLGNSKTKSPPQPPRPDYREQRRRGERPSQPPQAVPQASSAASASCGPATASCFSASSGSLPDDSGSTSDLIRAYRAQKERDFEDPYNGPGSSLRKLRAMCRLDYCGGSGEPGGVQRAFSASSASGAAGCCCASSGAGAAASSSSSSGSPHLYRSSSERRPATPAEVRYISPKHRLIKVESAAGGGAGDPLGGACAGGRTWSPTACGGKKLLNKCAASAAEESGAGKKDKVTIADDYSDPFDAKNDLKSKAGKGESAGYMEPYEAQRIMTEFQRQESVRSQHKGIQLYDTPYEPEGQSVDSDSESTVSPRLRESKLPQDDDRPADEYDQPWEWNRVTIPALAAQFNGNEKRQSSPSPSRDRRRQLRAPGGGFKPIKHGSPEFCGILGERVDPAVPLEKQIWYHGAISRGDAENLLRLCKECSYLVRNSQTSKHDYSLSLRSNQGFMHMKLAKTKEKYVLGQNSPPFDSVPEVIHYYTTRKLPIKGAEHLSLLYPVAVRTL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

